MANILA, Philippines — Molnupiravir, an anti-viral drug used in treating mild to moderate COVID-19, is now available to patients who are prescribed to take it through the Bayanihan E-Konsulta Program of the Office of the Vice President (OVP). ADVERTISEMENTRobredo said that the OVP would issue a guarantee letter Bayanihan E-Konsulta, its telemedicine program, which reviews patients’ cases virtually. Bayanihan E-Konsulta patients may get part of the first shipment of molnupiravir made in Southeast Asia, which arrived in the Philippines last Nov. 17. Last Nov. 9, another presidential aspirant, Sen. Panfilo Lacson, asked the Food and Drug Administration (FDA) to allow the commercial sale of molnupiravir. READ: Complacency under alert level 2 worries DOH https://newsinfo.inquirer.net/1511455/complacency-under-alert-level-2-worries-dohQualiMed Health Network, telemedicine, Bayanihan E-Konsulta, COVID-19 cases, COVID-19 pill, molnupiravir, Food and Drug Administration, FDA, 2022 elections, #2022candidates,ATMSubscribe to our daily newsletter By providing an email address.

Source: Philippine Daily Inquirer November 22, 2021 20:16 UTC